首页>
外国专利>
FOLATE RECEPTOR TARGETED COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF, AND COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT FOR PREVENTION, DIAGNOSIS OR TREATMENT OF CANCER
FOLATE RECEPTOR TARGETED COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF, AND COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT FOR PREVENTION, DIAGNOSIS OR TREATMENT OF CANCER
展开▼
机译:叶受体靶向的化合物及其药理学可接受的盐,其组成成分与癌症的预防,诊断或治疗相同
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to: a compound for targeting folate receptors, which has a peptide having an amino acid sequence of glycine-glycine-cysteine-glutamate (GGCE) bonded to folic acid, and which can be used for preventing, diagnosing, or treating cancer by specifically bonding to cancer cells having overexpressed folate receptors; or pharmaceutically acceptable salt thereof; and a composition comprising the same as an active component for preventing, diagnosing, or treating cancer.
展开▼